Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
Clin Mol Hepatol
; 19(4): 417-20, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-24459647
ABSTRACT
Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vasoconstritores
/
Síndrome Hepatorrenal
/
Lipressina
/
Necrose
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Mol Hepatol
Ano de publicação:
2013
Tipo de documento:
Article
País de publicação:
COREA DEL SUR
/
CORÉIA DO SUL
/
KR
/
SOUTH KOREA